To understand the role of host-derived CCL5 in cryo–thermal therapy triggering anti-tumor immunity, the 4T1 breast cancer model was established in WT and CCL5−/− transgenic mice and treated with cryo–thermal therapy. Here, CCL5 is linked to breast carcinoma.